Transvenous Before Surgical Hybrid Procedure

Joseph J Tiano1, Robert Drennan2, John Novella1

  • 1St. Vincent's Medical Center - Bridgeport, Connecticut.

Insights

The novel endocardial-before-epicardial ablation strategy successfully managed persistent atrial fibrillation (PeAF) and long-standing persistent atrial fibrillation (LSPeAF) in all patients. This approach offers a promising alternative for treating complex atrial arrhythmias.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Medical Devices

Background:

  • Persistent atrial fibrillation (PeAF) and long-standing persistent atrial fibrillation (LSPeAF) present significant management challenges.
  • Conventional and hybrid ablation approaches have shown limited clinical success in treating these complex arrhythmias.

Purpose of the Study:

  • To evaluate the efficacy and safety of a novel endocardial-before-epicardial ablation strategy for PeAF and LSPeAF.
  • To describe the comprehensive endovascular and epicardial procedures involved in this approach.

Main Methods:

  • A single-center study followed 40 patients with PeAF/LSPeAF over 12 months.
  • The procedure involved an endovascular phase (pulmonary vein isolation, linear lesions, CFAE ablation) followed by an epicardial phase (GP ablation, posterior wall ablation, LAA ligation).
  • All patients received implantable cardiac monitoring.

Main Results:

  • All 40 patients maintained sinus rhythm at 12-month follow-up.
  • Documented episodes of paroxysmal atrial arrhythmias did not persist after oral antiarrhythmic medication discontinuation.
  • No procedural complications were reported.

Conclusions:

  • The endocardial-before-epicardial approach significantly improved the management of PeAF and LSPeAF compared to conventional methods.
  • This strategy demonstrates a promising, complication-free option for managing complex atrial arrhythmias.
Abstract